We describe the commissioning of the first dedicated commercial total body irradiation (TBI) unit in clinical operation. The Best Theratronics GammaBeam 500 is a Co-60 teletherapy unit with extended field size and imaging capabilities. Radiation safety, mechanical and imaging systems, and radiation output are characterized. Beam data collection, calibration, and external dosimetric validation are described. All radiation safety and mechanical tests satisfied relevant requirements and measured dose distributions meet recommendations of American Association of Physicists in Medicine (AAPM) Report #17. At a typical treatment distance, the dose rate in free space per unit source activity using the thick flattening filter is 1.53 9 10 À3 cGy*min À1 *Ci À1 .
collection, calibration, and external dosimetric validation are described. All radiation safety and mechanical tests satisfied relevant requirements and measured dose distributions meet recommendations of American Association of Physicists in Medicine (AAPM) Report #17. At a typical treatment distance, the dose rate in free space per unit source activity using the thick flattening filter is 1.53 9 10 À3 cGy*min À1 *Ci À1 .
With a 14,000 Ci source, the resulting dose rate at the midplane of a typical patient is approximately 17 and 30 cGy/min using the thick and thin flattening filters, respectively, using the maximum source to couch distance. The maximum useful field size, defined by the 90% isodose line, at this location is 225 9 78 cm with field flatness within 5% over the central 178 9 73 cm. Measured output agreed with external validation within 0.5%. End-to-end testing was performed in a modified Rando phantom.
In-house MATLAB software was developed to calculate patient-specific dose distributions using DOSXYZnrc, and fabricate custom 3D-printed forms for creating patient-specific lung blocks. End-to-end OSLD and diode measurements both with and without lung blocks agreed with Monte Carlo calculated doses to within 5% and in-phantom film measurements validated dose distribution uniformity. Custom lung block transmission measurements agree well with design criteria and provide clinically favorable dose distributions within the lungs. Block placement is easily facilitated using the flat panel imaging system with an exposure time of 0.01 min. In conclusion, a novel dedicated TBI unit has been commissioned and clinically implemented. Its mechanical, dosimetric, and imaging capabilities are suitable to provide state-ofthe-art TBI for patients as large as 220 cm in height and 78 cm in width.
| INTRODUCTION
Total body irradiation (TBI) is commonly used as a preparatory regimen for bone marrow transplant for disseminated cancer. American
Association of Physicists in Medicine (AAPM) Report #17 "Aspects of Total Body Irradiation" describes the requirements and recommendations for TBI. 1 Since most radiotherapy centers perform relatively few such treatments, typical TBI involves adaptation of conventional radiotherapy equipment and treatment procedures to facilitate irradiation of the whole body. A common example is the use of a conventional linac rotated to deliver a lateral beam irradiating a patient placed a large distance away from the isocenter to create a field large enough to accommodate the entire patient. In many cases, the field size is still not large enough and the patient must be treated in the fetal position. Aside from the complexity of the treatment setup, the use of lateral fields is not optimal since the patient is thicker laterally than anteroposteriorly, resulting in greater dose heterogeneity. In addition, shielding the lungs to mitigate radiation pneumonitis, the most important common toxicity resulting from TBI, is much easier using anterior/posterior fields. Due to the difficulties accommodating TBI treatments using conventional radiotherapy treatment units, and the associated suboptimal treatment characteristics, some facilities performing large numbers of TBI treatments have devised dedicated TBI units by modifying existing clinical equipment to overcome these shortcomings. Some examples of these units are described in the literature using either linear accelerators [2] [3] [4] [5] or Co-60 units. 6-8. In 1994, our center modified a commercial Co-60 teletherapy unit (Theratron 780, Atomic Energy of Canada Ltd., Chalk River, Canada) to create a dedicated TBI unit similar to that described by Peters, et al. 9 Modifications included removal of the collimator and treatment couch and the construction of a custom flattening filter. A thin, movable couch with adjustable lung block tray was designed to support the patient a few cm off the floor with a gap underneath large enough to allow the assessment of lung block positioning with radiographic film. The surface of the couch was approximately 190 cm from the source. The removal of the collimator allowed the entire patient length to be included in the treatment fields. Patients were treated with an AP and a PA field using a supine and prone setup, respectively, and the custom flattening filter was designed to produce a uniform dose distribution over the lateral and longitudinal axes of the patient. This unit was well suited to provide uniform total body dose distributions and facilitate appropriate lung blocking and was operated from 1994 to 2016, delivering TBI treatments to over 700 patients in preparation for bone marrow transplant. In 2016, the GammaBeam 500 (Best Theratronics, Inc., Kanata, ON, Canada) became the first FDA approved commercial dedicated TBI unit. Its design is very similar to our previous in-house unit, however, it has greatly improved user interfaces, the height of the treatment head is adjustable, it projects a significantly larger field size, and the treatment couch includes an amorphous silicon flat-panel imaging device. Our in-house developed dedicated Co-60 TBI unit was decommissioned and replaced with this unit in October 2016. This work describes the commissioning processes and results for the first commercial dedicated TBI unit in clinical operation.
| MATERIALS AND METHODS
The GammaBeam 500 Total Body Irradiator is a Co-60 teletherapy unit designed to deliver a large field size at extended distance for and are referred to as the "fully shielded", "just shielded", and "fully exposed" phases of both the "exposure" and "return" processes. The
GammaBeam 500 treatment console provides access to the source translation time for each phase of translation with an accuracy of 10 ms. This allows a more sensitive evaluation of the reproducibility of the source translation process than simple measurement of the timer error. While the vertical position of the treatment head is adjustable, we decided for simplicity and safety to treat all patients with a single head height. In order to achieve the largest possible field size, we chose that height to be the maximum head height which is 247.0 cm from the source to the floor and 228. Absolute calibration was performed using a Farmer chamber within a 60 9 60 cm 2 water phantom filled to a depth of 30 cm with 40 9 40 9 30 cm 3 solid water placed on either side of the water phantom in the longitudinal direction. Since the field size is not adjustable we cannot create a 10 9 10 cm field size, and since we don't have a phantom large enough to cover the single fixed field size, we are not able to achieve full scatter. As such, we are not able to perform calibration per AAPM TG-51 guidelines, 10 however, the formalism of the TG-51 report was followed as closely as possible.
Photograph of the GB500 treatment unit and couch along with lung blocks placed on block tray.
Photograph of the attenuating flattening filter showing the filter shape and the light holes for field definition.
In addition, we followed the recommendations from AAPM Report #17 section 3.1 which state that one should (1) perform absolute calibration using large field geometry and the largest phantom possible, (2) correct for (a) dose that would be obtained for a phantom that covers the entire beam, and (b) dose that would be obtained within a deep phantom (full scatter), and (3) correct for patient dimensions in terms of both area and thickness when performing calculations for patient treatment. The unit has only one field size and this phantom is the largest we could create with existing equipment. We performed the recommended corrections to our measurements using Tables 2 and 3 from AAPM Report #17. Since Table 2 is limited to a field size of 75 9 75 cm 2 Detectors (OSLDs) were irradiated using the standard IROC acrylic irradiation block and setup. In addition, we made measurements using an identical acrylic calibration block with a hole drilled for a 0.053 cm 3 ionization chamber (Exradin A1SL, Standard Imaging, Middleton, WI, USA). The dose to muscle tissue in the calibration setup was calculated from the ionization chamber measurement and compared to the dose to muscle tissue calculated from the OSLD measurement.
In-house processes were developed for treatment planning and for the creation of lung blocks 13 image quality using a contrast-detail phantom, 15 and then used to image the Rando phantom with and without lung blocks to qualitatively evaluate the accuracy of lung block placement.
Finally, we developed a set of routine quality assurance tests associated with the dosimetric, mechanical, and radiation safety aspects of the unit and its operation. These tests, along with the associated tolerance and frequency, were based on regulatory requirements of the United States Nuclear Regulatory Commission (USNRC), AAPM recommendations for other radiotherapy delivery devices, and standard departmental procedures.
| RESULTS
All radiation survey results were within requirements both inside and In an attempt to most closely match our previous clinical experience and thus avoid any potential increase in pneumonitis or graft versus host disease due to a significant increase in dose rate, 17, 18 we chose to commission the treatment unit using the attenuating filter. When the source activity has decreased to a level requiring treatment times that are uncomfortable for patients, we will recommission the treatment field using the non-attenuating filter. In vivo dosimetry is performed for each treatment field by performing diode measurements on the patient surface for the first minute of the treatment field, thus leaving time to adjust the treatment time in the case that the measured dose deviates from the expected dose. The diode is calibrated in the Co-60 beam under conditions similar to patient irradiation and our clinical tolerance for the in vivo measurements is AE8%.
Independent validation measurements of the dose rate in free space were performed using a separate Farmer chamber and 0.125 cm 3 scanning chamber and were within 0.2% and 0.4% of the initial measurement, respectively. In-air measurements performed as a function of distance from the source followed an inverse square relationship within 1% to within 10 cm of the couch top, and in phantom measurements at d max with 10 cm backscatter followed an inverse square relationship within 0.3% to the couch top. eliminated to better illustrate the shape of the profile in two dimensions. All point measurements in the other three quadrants were within 1.5% of those in the fully measured quadrant shown here.
All TAR values calculated from measurements made at depths of 0.2-20 cm within the 50 9 50 cm 2 , 60 9 60 cm 2 , and 75 9 75 cm 2 equivalent square phantoms were within 2.0% of those used for our previous in-house modified treatment unit and from Table 1 End-to-end testing was performed initially without lung blocking. Table 1 shows calculated and measured doses along the surface of the phantom for a prescribed delivered dose of 100 cGy from the AP treatment field only. Table 2 T A B L E 2 Calculated and measured doses at various locations within the end-to-end phantom for a prescribed total delivered dose of 200 cGy from AP/PA fields (a) without and (b) with 2.5 cm thick lung blocks. are approximately 9 Gy for the entirety of both lungs. Figure 6 shows a photograph of the lung blocks created for the end-to-end testing with and without the PLA form. The forms can be printed to and blocks poured to any desired thickness in the case that we choose to use a different blocking regimen or total dose to the lungs. While the lung block tray has three sets of brackets allowing three different height settings, we chose to only use the highest setting which is 36 cm from the treatment couch. The other two sets of brackets were removed to eliminate the possibility of setting up the block tray at the wrong height. The imaging panel is used to verify the lung block positioning prior to treatment.
End-to-end testing was repeated with the 2.5 cm thick lung blocks described above and Table 2 QA procedures, frequencies, and tolerances developed for this treatment unit are listed in Table 3 . These satisfy our standard department procedures, and are similar to AAPM recommendations for other radiotherapy delivery devices for characteristics that these devices have in common, and satisfy regulatory requirements of the Emergency shutter system M/A Functional *For independent ion chamber validation, or relevant satisfactory agreement for independent organization (e.g., IROC).
CONCLUSI ONS
A novel dedicated TBI unit has been commissioned and clinically implemented. Its mechanical, dosimetric, and imaging capabilities are suitable to provide state-of-the-art TBI for patients as large as 225 cm in height and 78 cm in width. The uniformity of this treatment field is within 10% over this stated field size and within 5% over the central 178 cm and 73 cm in the longitudinal and lateral directions, respectively. All characteristics of this unit provide adequate capability to deliver TBI in accordance with tolerances recommended by AAPM Report #17.
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